Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication

J.G. Gregoor; J. van der Weide; H.M. Loovers; H.J. Megens; A.C.G. Egberts; E.R. Heerdink

Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication

Translated title of the contribution: Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication

J.G. Gregoor, J. van der Weide, H.M. Loovers, H.J. Megens, A.C.G. Egberts, E.R. Heerdink

Research output: Contribution to conference › Abstract › Other research output

Translated title of the contribution	Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication
Original language	Undefined/Unknown
Pages	S278, 657
Number of pages	2
Publication status	Published - 2010
Event	Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK - Duration: 1 Jan 2010 → …

Conference

Conference	Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK
Period	1/01/10 → …

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

Gregoor, J. G., van der Weide, J., Loovers, H. M., Megens, H. J., Egberts, A. C. G., & Heerdink, E. R. (2010). Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication. S278, 657. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.

@conference{f601a2bc9f7345f686a5446d87150f56,

title = "Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "J.G. Gregoor and {van der Weide}, J. and H.M. Loovers and H.J. Megens and A.C.G. Egberts and E.R. Heerdink",

note = "Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK; Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK ; Conference date: 01-01-2010",

year = "2010",

language = "Undefined/Unknown",

pages = "S278, 657",

}

Gregoor, JG, van der Weide, J, Loovers, HM, Megens, HJ, Egberts, ACG & Heerdink, ER 2010, 'Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication', Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK, 1/01/10 pp. S278, 657.

Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication. / Gregoor, J.G.; van der Weide, J.; Loovers, H.M. et al.
2010. S278, 657 Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication

AU - Gregoor, J.G.

AU - van der Weide, J.

AU - Loovers, H.M.

AU - Megens, H.J.

AU - Egberts, A.C.G.

AU - Heerdink, E.R.

N1 - Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK

PY - 2010

Y1 - 2010

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Abstract

SP - S278, 657

T2 - Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK

Y2 - 1 January 2010

ER -